Position in LH
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,480
+$212 QoQ
Shares Held
16
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#976
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bell Investment Advisors, Inc holds $861,969 across 21 Diagnostics & Research names. LH ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
4,065 | $539,953 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
200 | $100,272 | |
| 3 | DGX |
Quest Diagnostics Inc
|
310 | $65,704 | |
| 4 | DHR |
Danaher Corp /De/
|
178 | $33,905 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
44 | $23,163 | |
| 6 | NTRA |
Natera, Inc.
|
64 | $17,372 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
24 | $12,710 | |
| 8 | WAT |
Waters Corp /De/
|
31 | $11,626 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,480 | 16 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,268 | 16 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $4,264 | 17 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $5,454 | 19 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $4,987 | 19 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,422 | 19 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $3,898 | 17 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,246 | 19 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,087 | 25 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||